Sign in
Taking people in United StatesPhase 2

Behavioral help for adult smokers with poor sleep to quit smoking

Tests a behavioral program and varenicline for smokers with insomnia trying to quit.

Key facts

Who runs it
Yale University
Where
New Haven, United StatesSee the 2 sites
Trial code
Registry title
Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse
Status
Recruiting
Phase
Phase 2
People taking part
114 people, planned
Started
21 Apr 2025
Expected to end
Jun 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Experimental health intervention
  • Varenicline
Record updated
5 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who use a lot of tobacco or nicotine e-cigarettes and want to quit. It tests whether a behavioral program helps people quit by easing negative feelings and improving self-control.

Age
18 Years to 65 Years
Sex
All sexes can join.
Disease stage
Heavy tobacco use, including nicotine e-cigarettes, for more than 6 months. A test must show recent cigarette smoking or e-cigarette use. People must be able to read English and have a body mass index in the range the trial calls optimal.
Earlier treatment
People who are currently enrolled in other treatments cannot join.
Biomarker or test result
A biochemical test result showing recent cigarette smoking or e-cigarette use.

Main reasons for not taking part

  • Currently enrolled in other treatments
  • Brain or mental health conditions that could get in the way of the study, raise risk, or cause poor sleep
  • Medical reasons that rule out fMRI brain scans, varenicline or the behavioral treatment
  • Other causes of poor sleep for which the behavioral treatment helps less
  • Being pregnant or breastfeeding

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • English literate
  • report heavy tobacco use (including nicotine e-cigarettes) for >6 months
  • meet biochemical cut off for recent cigarette smoking or e-cigarette use
  • optimal body mass index

Who cannot take part

  • currently enrolled in other treatments
  • neuropsychiatric exclusions that could interfere with study participation, increase risk of adverse events, and/or induce deficient sleep
  • medical contraindications for fMRI, varenicline, and/or behavioral treatment
  • factors that cause deficient sleep and for which behavioral treatment has less benefit
  • women who are pregnant or nursing

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • Connecticut Mental Health CenterNew Haven, United StatesContact: Yu Chen, PhDTaking people
  • Yale UniversityNew Haven, United StatesContact: Yu Chen, PhDTaking people

About the trial

What the trial wants to find out

The study aims to investigate whether behavioral interventions promote cessation in adult smokers by ameliorating negative emotions and improving self-control and identify the neural markers of these effects.

The 2 groups in the trial

  • Experimental health interventionTreatment being tested

    Experimental health intervention and varenicline starting 4 weeks before and continuing for 4 weeks after a target quit date for a total of 8 weeks

    Treatment: Experimental health intervention and Varenicline

  • Control health interventionExisting treatment, for comparison

    Control health intervention and varenicline starting 4 weeks before and continuing for 4 weeks after a target quit date for a total of 8 weeks

    Treatment: Varenicline

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse
Plain-language title
Behavioral help for adult smokers with poor sleep to quit smokingGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT06609369, who can take part
Record updated
5 June 2026